Strategia DIVA w zwalczaniu pryszczycy

• Autorzy: Niedbalski W. , Fitzner A.

Warianty tytułu

EN

DIVA strategy in the eradication of foot-and-mouth disease

• Języki publikacji: PL

Abstrakty

EN

Foot-and-mouth disease virus (FMDV), in contrast to the antigen used for the production of FMD vaccine, can replicate in animals. As a result of infection the specific antibody to the viral structural proteins (SPs) and non-structural proteins (NSPs) of FMDV are synthesized. The laboratory diagnostic methods based on individual NSPs, e.g. 3D, 2C and 2B, as well as polypeptides, such as 3AB and 3ABC can be used for differentiation of infected and vaccinated animals (DIVA). This article presents the aim, principle, methods and results of applying DIVA strategy in the eradication of foot-and-mouth disease. The marker vaccines which enable differentiation between infected and vaccinated animals and appropriate ELISA serological tests for detection of antibodies to the NSPs of FMDV have been described. DIVA strategy makes it possible to reduce the economic losses and restore possibilities of international trade in animals and animal products. This strategy may be an alternative of the administrative “stamping-out” eradication method. The essential aim of DIVA strategy is realization of the so-called “vaccinate-to-live” policy, which is based on the principle that vaccinated animals exposed to FMDV will not transmit the virus. These animals are not epidemiologically risky, and therefore do not have to be eliminated. It is necessary to develop new vaccines and improve those already used as well as the application of reliable diagnostic tests to detect FMDV in vaccinated livestock populations.

Słowa kluczowe

PL

choroby zwierzat; pryszczyca; eradykacja chorob; zwalczanie chorob zwierzat; strategia DIVA; szczepienia ochronne; szczepionki

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2017
• Tom: 73
• Numer: 01
• Opis fizyczny: s.23-27,rys.,bibliogr.

Twórcy

autor

Niedbalski W.

• Zakład Pryszczycy, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy, ul. Wodna 7, 98-220 Zduńska Wola

autor

Fitzner A.

• Zakład Pryszczycy, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy, ul. Wodna 7, 98-220 Zduńska Wola

Bibliografia

• Alexandersen S., Mowat N.: Foot-and-mouth disease: host range and pathogenesis. Curr. Top. Microbiol. Immunol. 2005, 288, 9-42.
• Alexandersen S., Zhang Z., Donaldson A. I., Garland A. J.: The pathogenesis and diagnosis of foot-and-mouth disease. J. Comp. Path. 2003, 129, 1-36.
• Bergmann I. E., Malirat V., Neitzert E., Correa Melo E.: Vaccination: foot-and-mouth disease experience in South America. Dev. Biol. (Basel) 2004, 119, 273-282.
• Bouma A., Elbers A. R. W, Dekker A., de Koeijer A., Bartels C., Vellema P., van der Wal P., van Rooij E. M. A, Pluimers F. H., de Jong M. C. M.: The foot-and-mouth disease epidemic in the Netherlands in 2001. Prev. Vet. Med. 2003, 57, 155-166.
• Brocchi E., Bergmann I. E., Dekker A., Paton D. J., Sammin D. J., Greiner M., Grazioli S., de Simone F., Yadin H., Haas B., Bulut N., Malirat V., Neitzer E., Goris N., Parida S., Sorensen K., de Clercq K.: Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine 2006, 24, 6966-6977.
• Brocchi E., Sorensen K., Mackay D.: The use of serology as part of the exit strategy to the 1996 epidemic of FMD in the Balkans. Dev. Biol. (Basel) 2004, 119, 283-292.
• Chung W. B., Liao P. C., Yang P. C., Chen S. P., Jong N. H., Steu T. W.: Surveillance of FMD virus non-structural antibodies in pig populations involved in an eradication programme. Vet. Rec. 2003, 152, 595-597.
• Clavijo A., Wright P., Kitching P.: Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease. Vet. J. 167, 2004, 9-22.
• Diego M. de, Brocchi E., Mackay D., De Simone F.: The non-structural poliprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch. Virol. 1997, 142, 2021-2033.
• Doel T. R.: FMD vaccines. Virus Res. 2003, 91, 81-99.
• Domingo E., Escarmis C., Baranowski E., Ruiz-Jarabo C. M., Carrillo E., Nunez J. I., Sobrino F.: Evolution of foot-and-mouth disease virus. Virus Res. 2003, 91, 47-63.
• Domingo E., Escarmis C, Martinez M. A., Martinez-Salas E., Mateu M. G.: Foot-and-mouth disease virus populations are quasispecies. Curr. Top. Microbiol. Immunol. 1992, 176, 33-47.
• Foord A. J., Muller J. D., Yu M., Wang L. F., Heine H. G.: Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC. J. Immunol. Methods 2007, 321, 142-151.
• Grubman M. J.: Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. Biologicals 2005, 33, 227-234.
• Grubman M. J., Baxt B.: Foot-and-mouth disease. Clin. Microbiol. Rev. 2004, 17, 465-493.
• Inoue T., Parida S., Paton D. J., Linchongsubongkoch W., Mackay D., Oh Y., Aunpomma D., Gubbins S., Saeki T.: Development and evaluation of an indirect enzyme-linked immunosorbent assay for detection of foot-and-mouth disease virus nonstructural protein antibody using a chemically synthesized 2B peptide as antigen. J. Vet. Diagn. Invest. 2006, 18, 545-552.
• Kitching R. P., Hughes G. J.: Clinical variation in foot and mouth disease: sheep and goats. Rev. Sci. Tech. 2002, 21, 505-512.
• Kweon Y. H., Ko Y. J., Kim W. I., Lee S. Y., Naha J. J., Lee K. N., Sohna H. J., Choi K. S., Hyuna B. H., Kanga S. W., Joo Y. S., Lubroth J.: Development of foot-and-mouth disease NSP ELISA and its comparison with differential diagnostic methods. Vaccine 2003, 21, 1409-1414.
• Li Z., Yin X., Yi Y., Li X., Li B., Lan X., Zhang Z., Liu J.: FMD subunit vaccine produced using a silk-worm-baculovirus expression system: protective efficacy against two type Asia 1 isolates in cattle. Vet. Microbiol. 2011, 149, 99-103.
• Lubroth J., Brown F.: Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. Res. Vet. Sci. 1995, 59, 70-78.
• Mackay D. K. J., Forsyth M. A., Davies P. R., Berlinzani A., Belsham G. J., Flint M., Ryan M. D.: Differentiating infection from vaccination in foot-andmouth disease using a panel of recombinant non-structural proteins in ELISA. Vaccine 1998, 16, 446-459.
• Martin P. A., Cameron A. R., Greiner M.: Demonstrating freedom from disease using multiple complex data sources: a new methodology based on scenario trees. Prev. Vet. Med. 2007, 79, 71-97.
• Niedbalski W.: Comparison of three ELISA kits for the detection of antibodies against foot-and-mouth disease virus non-structural proteins. Bull. Vet. Inst. Pulawy 2005, 49, 147-151.
• Niedbalski W.: Detection of foot-and-mouth disease virus infection in vaccinated cattle. Pol. J. Vet. Sci. 2005, 8, 283-287.
• Niedbalski W., Haas B.: Differentiation of infection from vaccination by detection of antibodies to the non-structural protein 3ABC of foot-and-mouth disease virus. Bull. Vet Inst. Pulawy 2003, 47, 51-60.
• Niedbalski W., Kęsy A.: Zastosowanie testu 3ABC-ELISA do różnicowanie przeciwciał pryszczycowych powstałych w wyniku zakażenia lub immunizacji wrażliwych zwierząt. Med. Weter. 1998, 54, 695-697.
• O’Donnel V. K., Boyle D. B., Sproat K., Fondevila N. A., Forman A., Schudel A., Smitsaart E. N.: Detection of antibodies against foot-and-mouth disease virus using a liquid-phase blocking sandwich ELISA (LPBE) with a bioengineered 3D protein. J. Vet. Diagn. Invest. 1996, 8, 143-150.
• Parida S.: Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Expert Rev. Vaccines 2009, 8, 347-365.
• Parida S., Anderson J., Cox S. J., Barnett P. V., Paton D. J.: Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance. Vaccine 2006, 24, 1107-1116.
• Parida S., Fleming L., Gibson D., Hamblin P. A., Grazioli S., Brocchi E., Paton D. J.: Bovine serum panel for evaluating foot-and-mouth disease virus non-structural protein antibody tests. J. Vet. Diagn. Invest. 2007, 19, 539-544.
• Paton D. J., de Clercq K., Greiner M., Dekker A., Brocchi E., Bergman I., Sammin D. J., Gubbins S., Parida S.: Application of non-structural protein antibody test in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine 2006, 24, 6503-6512.
• Paton D. J., Ferris N. P., Hutchings G. H., Li Y., Swabey K., Keel P., Hamblin P., King D. P., Reid S. M., Ebert K., Parida S., Savva S., Georgiou K., Kakoyiannis C.: Investigations into the cause of FMDV seropositive small animals in Cyprus during 2007. Transbound. Emerg. Dis. 2009, 56, 321-328.
• Paton D. J., Fussel A. E., Vosloo W., Dekker A., de Clercq K.: The use of serosurveys following emergency vaccination, to recover the status of “foot-and-mouth disease free where vaccination is not practised”. Vaccine 2014, 32, 7050-7056.
• Piccone M. E., Rieder E., Mason P. W., Grubman M. J.: The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 1995, 69, 5376-5382.
• Rodriquez A., Dopazo J., Saiz J. C., Sobrino F.: Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch. Virol. 1994, 136, 123-131.
• Silberstein E., Kaplan G., Taboga O., Duffy S., Palma E.: Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural protein. Arch. Virol. 1997, 142, 795-800.

Identyfikatory

DOI

10.21521/mw.5628